Novel transcript, antisense to PHF20L1 (ENSG00000223697)

ENSG00000223697 refers to a novel, non-coding transcript located antisense to the PHF20L1 gene. There is no evidence that this transcript encodes a protein or that it has a defined biological function. Its presence is a result of high-throughput transcriptome annotation rather than experimental characterization. In contrast, PHF20L1 (Plant homeodomain finger protein 20-like 1) is a protein-coding gene encoding a methyl-lysine reader involved in epigenetic regulation and cancer, but ENSG00000223697 does not correspond to this protein or its functions[1][2][3]. This entry is not a canonical therapeutic target, receptor, enzyme, transporter, or typical drug target, and there is no evidence it is currently considered therapeutically relevant or validated[1][2][3]. The identifier likely reflects preliminary or computational transcript annotation and not an active molecular entity in pharmacology or disease. If you need information about the PHF20L1 protein-coding gene (which IS a therapeutic target and of biomedical interest in epigenetics and cancer), please clarify. But as specified, "novel transcript, antisense to PHF20L1" (ENSG00000223697) is not a protein-coding or functionally validated target.

Other names

PHF20L1 antisense RNA